The investigators would like to study the differences in the quality of Platelet Rich Plasma (PRP) between two different machines in those with knee osteoarthritis. Knee osteoarthritis means your cartilage has been worn down, and it affects your knee joint. Both machines, the APEX Biologix XCELL PRP System and the Emcyte PurePRP Supraphysiologic Concentrating System, are FDA approved, commercially available, and makes PRP. The investigators will check if the platelets in the PRP have different amounts or work differently. The investigators will also assess participants symptoms after the injection and compare the two different preparation systems.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
20
The Platelet Rich Plasma (PRP) participants will receive in this study will be made by Emcyte PurePRP Supraphysiologic Concentrating System or the APEX Biologix XCELL PRP System.
Platelet Rich Plasma (PRP) will be made by the Emcyte PurePRP Supraphysiologic Concentrating System.
Platelet Rich Plasma (PRP) will be made by APEX Biologix XCELL PRP System.
University of California San Francisco
San Francisco, California, United States
Cellular composition and quantity using Horiba Cell counter
Compare cellular composition and quantifying PRP products between EmCyte PurePRP versus APEX Biologix XCELL PRP manufacturing systems using a Horiba Cell counter.
Time frame: Day 1
Platelet Activation
Compare platelet activation state, aggregation capacity, and transcriptome between PRP manufacturing systems.
Time frame: Day 1
Patient Reported Outcomes: Western Ontario and McMaster Universities Arthritis Index (WOMAC)
Link PRP characteristics to change from baseline in Pain, Stiffness, and Physical Function at 6 months as assessed by Western Ontario and McMaster Universities Arthritis Index (WOMAC).
Time frame: Enrollment to 6 months.
Patient Reported Outcome: Short Form-12 Health Survey
Link PRP characteristics to change from baseline in health and ability to complete usual activities at 6 months as assessed by Short Form-12 Health Survey, a health quality of life survey.
Time frame: Enrollment to 6 months
Activity Monitor & PRP Characteristics
Link PRP count and characteristics to change from baseline activity to 6 months as assessed by activity sensors.
Time frame: Enrollment to 6 months
Patient Reported Outcomes: Visual Analog Scale
Link PRP characteristics to change from baseline in Pain at 6 months as assessed by Visual Analog Scale (VAS).
Time frame: Enrollment to 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.